-
Global Life Science Leader[]BGI’s unparalleled understanding of its clients’ competitive landscape in conjunction with best-in-class executive through board level recruiting makes it the search firm of choice with clients that are truly focused on driving their success and bringing exceptional shareholder value.CEOBoardExecutiveLearn More
-
Global Life Science Leader[]BGI’s unparalleled understanding of its clients’ competitive
landscape in conjunction with best-in-class executive
through board level recruiting makes it the search firm
of choice with clients that are truly focused on driving
their success and bringing exceptional shareholder value.BiotechnologyPharmaceuticalMedical DeviceContract ServicesLearn More -
Global Life Science Leader[]BGI’s unparalleled understanding of its clients’ competitive
landscape in conjunction with best-in-class executive
through board level recruiting makes it the search firm
of choice with clients that are truly focused on driving
their success and bringing exceptional shareholder value.Saving LivesImproving TreatmentsLearn MoreMaximizing Shareholder ValueFinding CuresHelping Clients
Encompassing all Executive through Board Positions in Life Sciences
Director of the Board

Chief Executive Officer

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.
Chairman of the Board

Chief Financial Officer

Formerly Aastrom Biosciences
Chief Operating Officer

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company
Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.
In The News
Bavarian Nordic signs ‘larger’ monkeypox vaccine supply deal with unnamed country aliu Wed, 05/25/2022 – 08:38
US to provide Bavarian Nordic’s vaccine Jynneos to some at risk for monkeypox, CDC says kdunleavy Tue, 05/24/2022 – 15:30
The biotech plans to seek FDA approval for its soft-tissue tumor treatment after positive study results. But investors still sent the stock down by nearly 10%.
The two companies are each developing new types of medicines that they hope can soon win FDA approval for treating the autoimmune disease.
One day after the U.S. began releasing supplies of an approved Bavarian Nordic shot, Moderna said it's beginning development of its own vaccine against the virus.
With inhaled version of Tyvaso, United Therapeutics sniffs a potential blockbuster kdunleavy Tue, 05/24/2022 – 09:44